F-group (family)
11.1.1.230 YBD
Ligands and drugs
224
Member domains
177
with ligand contacts (≤ 4 Å)
79.0% of members
128
with DrugDomain annotations
57.1% of members
85
with a DrugBank compound
37.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 11.1.1.230 belongs to X-group 11 Immunoglobulin-like beta-sandwich, which binds 8.0 ligand superclasses per 20 proteins, broader than 58% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08231 | MYR | Myristic acid | 44 |
| DB03796 | PLM | Palmitic Acid | 8 |
| DB02266 | FLF | Flufenamic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MYR | MYRISTIC ACID | 53 |
| PLM | PALMITIC ACID | 9 |
| CL | CHLORIDE ION | 8 |
| WCF | 4-[(2~{S})-5-chloranyl-6-fluoranyl-2-phenyl-2-[(2~{S})-pyrrolidin-2-yl]-3~{H}-1-benzofuran-4-yl]-5-fluoranyl-6-(2-hydroxyethyloxy)-~{N}-methyl-pyridine-3-carboxamide | 5 |
| 1PG | 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL | 4 |
| CAmetal | CALCIUM ION | 4 |
| JIK | 1-cyclopentylpyrazolo[3,4-b]pyridine-5-carboxylic acid | 4 |
| KK9 | N-[3-(4-chloranylphenoxy)-4-methyl-phenyl]propanamide | 4 |
| KMU | 2-[(2~{S})-2-(aminomethyl)-5-chloranyl-2-phenyl-3~{H}-1-benzofuran-4-yl]benzamide | 4 |
| KNE | [(2~{S})-5-chloranyl-2-phenyl-3~{H}-1-benzofuran-2-yl]methanamine | 4 |
| U3O | (2~{R})-2-[2-chloranyl-5-[2-chloranyl-4-(trifluoromethyl)phenoxy]phenyl]sulfanylpropanoic acid | 4 |
| A1L1N | (2~{R})-2-fluoranyl-1-[7-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-isoquinolin-2-yl]propan-1-one | 3 |
| A1L1O | 1-[7-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-isoquinolin-2-yl]propan-1-one | 3 |
| A1L3K | ~{N}-[(1~{S})-1-phenylethyl]-5-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-isoquinoline-2-carboxamide | 3 |
| A1L3M | ~{N}-[(1~{S})-4-azanyl-4-oxidanylidene-1-phenyl-butyl]-5-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-isoquinoline-2-carboxamide | 3 |
| G9C | N-[(1S)-1-pyridin-2-ylethyl]-8-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide | 3 |
| 5E4 | 2-[(3-bromophenyl)amino]benzoic acid | 2 |
| 87L | (2S)-2-phenyl-2-pyrrol-1-yl-ethanoic acid | 2 |
| A1H3W | ~{N}-[2-(5-phenylmethoxy-1~{H}-indol-3-yl)ethyl]methanesulfonamide | 2 |
| A1H3Y | 2-(5-phenylmethoxy-1~{H}-indol-3-yl)ethanol | 2 |